1-(2-Fluorophenyl)-4-{[2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl}piperazine

Catalog No. :
ACHDRU469
CAS No. :
338415-61-5
Molecular Formula :
C25H25FN4O
Molecular Weight :
416.5

IUPAC Name:3-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-2-(4-methoxyphenyl)imidazo[1,2-a]pyridine

1-(2-Fluorophenyl)-4-{[2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl}piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2-Fluorophenyl)-4-{[2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl}piperazine
IUPAC Name3-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-2-(4-methoxyphenyl)imidazo[1,2-a]pyridine
MDL No.MFCD01568984
Molecular FormulaC25H25FN4O
Molecular Weight416.5
SMILESCOC1=CC=C(C2=C(CN3CCN(C4=CC=CC=C4F)CC3)N5C=CC=CC5=N2)C=C1
InChI KeyHWJVBJJKIFMZCH-UHFFFAOYSA-N
Synonym4-(3-([4-(2-FLUOROPHENYL)PIPERAZINO]METHYL)IMIDAZO[1,2-A]PYRIDIN-2-YL)PHENYL METHYL ETHER;3-([4-(2-FLUOROPHENYL)PIPERAZINO]METHYL)-2-(4-METHOXYPHENYL)IMIDAZO[1,2-A]PYRIDINE;1-(2-fluorophenyl)-4-{[2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl}piperazine;Imidazo[1,2-a]pyridine, 3-[[4-(2-fluorophenyl)-1-piperazinyl]methyl]-2-(4-methoxyphenyl)-
CAS No.338415-61-5

Synthetic Route by SureRoute

1. ACHDRU469 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHDRU469 route product structure diagram
    ACHDRU469338415-61-5
Inquiry

2. ACHDRU469 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHDRU469 route product structure diagram
    ACHDRU469338415-61-5
Inquiry

Comments (0)